Danatlas
Latest round
- Angel
Last raised
- Jun 2022
Total raised
- Undisclosed
Investors
- 2
About Danatlas
Based in Beijing, China, and established in 2021, Danatlas is a developer of anticancer drugs that focuses on the R&D of new drugs for tumors and other diseases. Founder, Chairman and CEO, Zhou Wenlai, holds a PhD in Molecular Biology from the University of Melbourne and a postdoctoral fellow from the University of California, San Diego. He was formerly Chief Biologist and Senior Vice President of Jacobs Pharmaceuticals and Director of the Oncology Division of Novartis Institutes for BioMedical Research. The company has a branch office in Boston. It was rated as a National High-tech Enterprise and Beijing Specialized, Refined, Featured and Original SMEs. Danatlas has developed a synthetic lethal drug development platform and a translational medicine platform. The company's core product is the PARG inhibitor (DAT-2645), which is undergoing a Phase I dose escalation study in China. It has multiple product pipelines, including DAT-1000, DAT-5000, DAT-6000, etc. Its platforms and products focus on cancer, inflammation, blood, metabolic diseases and other fields. The company generates revenue by providing new drugs for tumors, inflammation, blood and other diseases.
Who invested in Danatlas
2 investors across 2 rounds
See all investors in Danatlas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Danatlas
Who invested in Danatlas?
Danatlas has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Danatlas raised?
Danatlas has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Danatlas last raise money?
Danatlas's most recent round on record is a Angel, in Jun 2022.
What does Danatlas do?
Based in Beijing, China, and established in 2021, Danatlas is a developer of anticancer drugs that focuses on the R&D of new drugs for tumors and other diseases.
Where is Danatlas headquartered?
Danatlas is headquartered in Beijing, China.
Which VCs invest in companies like Danatlas?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Danatlas's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Danatlas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.